In recent years, more emphasis has been placed on testing for HIV. The idea behind this drive is that if people know their status, they'll be able to seek treatment and support. One approach that's become fairly common is ...
Nov 28, 2018
0
2
South Africa has a dire shortage of organ donors. This means that doctors struggle to find suitable donor organs for critically ill patients who would die without receiving a transplant. Sometimes they have to make tough ...
Oct 4, 2018
0
18
Point-of-care tests could save lives by allowing faster diagnosis and treatment of the leading cause of death for people with HIV.
Sep 28, 2018
0
1
In the quest to develop a vaccine that triggers the immune system to prevent HIV infection, researchers have focused on identifying and eliciting a particular type of antibody that is capable of neutralizing the virus.
Sep 27, 2018
0
64
Thanks to improvements in antiretroviral therapy, HIV is now a manageable condition. Yet even the best drugs do not entirely eliminate the virus, which latently lingers in the body, threatening to rise to dangerous levels ...
Sep 26, 2018
0
95
A clinical trial testing infusions of combination antibodies in people living with HIV has begun at the National Institutes of Health. The early-phase clinical trial will evaluate whether periodic infusions of two highly ...
Sep 20, 2018
0
0
Around one percent of people infected with HIV produce antibodies that block most strains of the virus. These broadly acting antibodies provide the key to developing an effective vaccine against HIV. Researchers from the ...
Sep 10, 2018
0
14
Long-lasting control of HIV infection without antiretroviral therapy (ART) is a feasible goal that deserves vigorous pursuit, Anthony S. Fauci, M.D., will assert during a lecture on Wednesday, July 25 at the 22nd International ...
Jul 25, 2018
0
3
Individuals produce unique sets of antibodies in response to HIV infection. That diversity—and the ability of the human immunodeficiency virus to rapidly change its protein coat to avoid detection—has stymied efforts ...
Jun 11, 2018
0
3
An experimental vaccine regimen based on the structure of a vulnerable site on HIV elicited antibodies in mice, guinea pigs and monkeys that neutralize dozens of HIV strains from around the world. The findings were reported ...
Jun 4, 2018
0
458
